^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Mantle Cell Lymphoma |
| Regimen: | R-GemOx (gemcitabine + oxaliplatin + Rituxan (rituximab)) |
| Direction: | Sensitive |
Evidence:
Source:
Published date:
01/20/2021
Excerpt:
Mantle Cell Lymphoma: SECOND-LINE AND SUBSEQUENT THERAPY…Useful under Certain Circumstances…GemOx (gemcitabine + oxaliplatin) + rituximab
